Security record · archived quarter
CTMX
CytomX Therapeutics, Inc. · Healthcare · Biotechnology
6Tracked holders
—Δ holders
7.95MShares held
$9.70MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 73 | +11 | 136.41M | $511.64M | +18 | −7 |
| Q1 2026 | 64 | +15 | 111.19M | $522.57M | +20 | −5 |
| Q4 2025 | 49 | -1 | 71.30M | $303.77M | — | −1 |
| Q3 2025 | 14 | 0 | 41.38M | $131.99M | — | — |
| Q2 2025 | 11 | 0 | 36.17M | $82.10M | — | — |
| Q1 2025 | 8 | +1 | 8.01M | $5.09M | +1 | — |
| Q4 2024 | 7 | 0 | 9.00M | $9.27M | +1 | −1 |
| Q3 2024 | 6 | 0 | 8.17M | $9.64M | — | — |
| Q2 2024 | 6 | — | 7.95M | $9.70M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 3.00M | — | $3.66M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Millennium Management ✦ | 1.85M | — | $2.25M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 1.18M | — | $1.44M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 769.50K | — | $939,006 | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 769.50K | — | $939,006 | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 661.95K | — | $807,575 | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 494.64K | — | $603,464 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 178 holders, 193.14M shares, $906.86M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API